Mesa Laboratories (MLAB)
Mesa Laboratories on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as industrial instruments for measurement, display, and control.
447K
Short interest
settlement 2026-09-30
3.7
Days to cover
+0.7 days vs prior
65.5%
Short share of volume
2026-10-12
5,200
Fails to deliver
settlement 2026-09-03
Thu 5 Nov
Next earnings
estimated date
$102K
Insider flow, 90 days
2 buys, 1 sells
As of 2026-10-12.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in MLAB is 447,048 shares, up 13,066 shares over the last month. Over the last 48 readings it ranged from 122,974 shares (15 November 2024) to 447,048 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 121K shares a day that is 3.7 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/mlab" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 447,048 | +10.8% | 120,938 | 3.70 |
| 2026-09-15 | 403,559 | -7.0% | 133,817 | 3.02 |
| 2026-08-31 | 433,982 | +28.5% | 159,824 | 2.72 |
| 2026-08-14 | 337,738 | +4.2% | 170,033 | 1.99 |
| 2026-07-31 | 324,102 | +18.2% | 129,676 | 2.50 |
| 2026-07-15 | 274,176 | -0.7% | 227,097 | 1.21 |
| 2026-06-30 | 276,170 | +15.5% | 208,767 | 1.32 |
| 2026-06-15 | 239,181 | -14.5% | 267,779 | 1.00 |
| 2026-05-29 | 279,822 | +20.5% | 210,603 | 1.33 |
| 2026-05-15 | 232,139 | +16.9% | 137,968 | 1.68 |
| 2026-04-30 | 198,615 | +0.1% | 107,880 | 1.84 |
| 2026-04-15 | 198,395 | -10.1% | 105,205 | 1.89 |
| 2026-03-31 | 220,739 | -1.7% | 108,776 | 2.03 |
| 2026-03-13 | 224,457 | +0.3% | 173,572 | 1.29 |
| 2026-02-27 | 223,687 | +5.7% | 78,520 | 2.85 |
| 2026-02-13 | 211,720 | -5.1% | 84,004 | 2.52 |
| 2026-01-30 | 223,102 | -9.6% | 80,261 | 2.78 |
| 2026-01-15 | 246,660 | -12.1% | 110,124 | 2.24 |
| 2025-12-31 | 280,731 | -0.9% | 88,778 | 3.16 |
| 2025-12-15 | 283,413 | +1.1% | 122,726 | 2.31 |
| 2025-11-28 | 280,290 | -14.2% | 242,342 | 1.16 |
| 2025-11-14 | 326,568 | -10.4% | 121,060 | 2.70 |
| 2025-10-31 | 364,590 | +6.1% | 80,182 | 4.55 |
| 2025-10-15 | 343,694 | +3.3% | 104,212 | 3.30 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 12 October 2026, the short share of MLAB volume is 65.5%, up 27.3 points over the last five sessions. Over the last 30 readings it ranged from 28.1% (30 September 2026) to 83.0% (1 September 2026). The latest reading is 5.5 points above the 30-session average of 60.0%, on 25K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-12 | 17K | 25K | 65.5% | 0 |
| 2026-10-09 | 14K | 24K | 58.2% | 0 |
| 2026-10-08 | 24K | 42K | 56.6% | 0 |
| 2026-10-07 | 10K | 17K | 58.6% | 0 |
| 2026-10-06 | 16K | 30K | 55.0% | 0 |
| 2026-10-05 | 25K | 64K | 38.2% | 0 |
| 2026-10-02 | 16K | 26K | 60.9% | 0 |
| 2026-10-01 | 12K | 29K | 42.4% | 0 |
| 2026-09-30 | 16K | 57K | 28.1% | 0 |
| 2026-09-29 | 26K | 46K | 56.7% | 0 |
| 2026-09-28 | 10K | 17K | 56.2% | 0 |
| 2026-09-25 | 27K | 71K | 38.3% | 0 |
| 2026-09-24 | 33K | 74K | 44.4% | 0 |
| 2026-09-23 | 24K | 36K | 65.0% | 0 |
| 2026-09-22 | 24K | 36K | 65.5% | 0 |
| 2026-09-21 | 26K | 34K | 76.5% | 0 |
| 2026-09-18 | 18K | 26K | 68.6% | 21 |
| 2026-09-17 | 18K | 25K | 74.6% | 66 |
| 2026-09-16 | 25K | 44K | 56.4% | 54 |
| 2026-09-15 | 26K | 43K | 59.7% | 0 |
| 2026-09-14 | 24K | 40K | 60.5% | 0 |
| 2026-09-11 | 28K | 55K | 51.3% | 0 |
| 2026-09-10 | 28K | 53K | 52.4% | 15 |
| 2026-09-09 | 33K | 47K | 69.7% | 0 |
| 2026-09-08 | 30K | 53K | 55.8% | 0 |
| 2026-09-04 | 18K | 24K | 73.7% | 0 |
| 2026-09-03 | 38K | 53K | 71.9% | 0 |
| 2026-09-02 | 44K | 60K | 73.7% | 2,175 |
| 2026-09-01 | 31K | 37K | 83.0% | 0 |
| 2026-08-31 | 47K | 57K | 82.3% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 3 September 2026, the fails-to-deliver balance in MLAB is 5,200 shares, up 1 share over the last settlement date. Over the last 30 readings it ranged from 1 share (27 April 2026) to 5,200 shares (3 September 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-03 | 5,200 | $130.65 | $679K |
| 2026-09-02 | 5,199 | $125.47 | $652K |
| 2026-08-28 | 1,366 | $128.65 | $176K |
| 2026-08-27 | 1,614 | $127.15 | $205K |
| 2026-08-21 | 218 | $119.15 | $26K |
| 2026-08-20 | 103 | $119.72 | $12K |
| 2026-08-04 | 12 | $104.43 | $1K |
| 2026-08-03 | 140 | $100.81 | $14K |
| 2026-07-31 | 216 | $101.04 | $22K |
| 2026-07-29 | 898 | $101.10 | $91K |
| 2026-07-08 | 91 | $96.16 | $9K |
| 2026-07-02 | 22 | $104.39 | $2K |
| 2026-06-17 | 116 | $99.68 | $12K |
| 2026-06-03 | 70 | $106.66 | $7K |
| 2026-05-28 | 239 | $90.80 | $22K |
| 2026-04-30 | 1 | $95.76 | $96 |
| 2026-04-27 | 1 | $97.96 | $98 |
| 2026-04-24 | 51 | $96.90 | $5K |
| 2026-03-18 | 208 | $81.69 | $17K |
| 2026-03-10 | 24 | $87.69 | $2K |
| 2026-02-27 | 636 | $95.56 | $61K |
| 2026-02-02 | 46 | $78.76 | $4K |
| 2025-12-30 | 5 | $79.98 | $400 |
| 2025-12-18 | 7 | $79.77 | $558 |
| 2025-12-17 | 536 | $78.63 | $42K |
| 2025-12-10 | 7 | $77.87 | $545 |
| 2025-12-05 | 2 | $77.15 | $154 |
| 2025-11-25 | 200 | $77.74 | $16K |
| 2025-11-21 | 80 | $71.60 | $6K |
| 2025-11-20 | 94 | $70.72 | $7K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONOver the last 90 days MLAB insiders reported 2 open-market buys ($902K) against 1 sell ($800K), so the dollar flow leans toward buying. Latest filing: Tripeny R Tony (Director) on 2026-08-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-15 | Tripeny R Tony | Director | Option exercise | 3K | $0.00 | $0 | 9K |
| 2026-08-15 | Sullivan John James | Director | Option exercise | 3K | $0.00 | $0 | 21K |
| 2026-08-15 | Ladiwala Shiraz Shabanali | Director | Option exercise | 4K | $0.00 | $0 | 12K |
| 2026-08-15 | Hall Shannon | Director | Option exercise | 3K | $0.00 | $0 | 7K |
| 2026-08-15 | Capone Mark Christopher | Director | Option exercise | 3K | $0.00 | $0 | 6K |
| 2026-08-15 | Alltoft Jennifer Sadie | Director | Option exercise | 3K | $0.00 | $0 | 8K |
| 2026-08-13 | Sullivan John James | Director | Sell | 7K | $112.80 | $800K | 18K |
| 2026-08-13 | Tripeny R Tony | Director | Buy | 900 | $113.69 | $102K | 6K |
| 2026-08-13 | Kadia Siddhartha | President and CEO | Buy | 7K | $112.80 | $800K | 7K |
| 2026-06-22 | Sakys John | CFO | Sell | 3K | $89.50 | $253K | 20K |
| 2026-06-22 | Crennen Lyndsey Elizabeth | CAO | Sell | 442 | $89.50 | $40K | 2K |
| 2026-06-22 | Archbold Brian David | SVP Operations | Sell | 3K | $89.50 | $225K | 6K |
| 2026-06-18 | Sakys John | CFO | Grant | 2K | $95.10 | $217K | 23K |
| 2026-06-18 | Sakys John | CFO | Option exercise | 1K | $95.10 | $99K | 18K |
| 2026-06-18 | Sakys John | CFO | Option exercise | 3K | $95.10 | $262K | 20K |
| 2026-06-18 | Crennen Lyndsey Elizabeth | CAO | Option exercise | 368 | $95.10 | $35K | 2K |
| 2026-06-18 | Crennen Lyndsey Elizabeth | CAO | Grant | 263 | $95.10 | $25K | 2K |
| 2026-06-18 | Crennen Lyndsey Elizabeth | CAO | Option exercise | 125 | $95.10 | $12K | 2K |
| 2026-06-18 | Crennen Lyndsey Elizabeth | CAO | Option exercise | 233 | $95.10 | $22K | 2K |
| 2026-06-18 | Archbold Brian David | SVP Operations | Grant | 2K | $95.10 | $177K | 9K |
| 2026-06-18 | Archbold Brian David | SVP Operations | Option exercise | 2K | $95.10 | $236K | 7K |
| 2026-06-18 | Archbold Brian David | SVP Operations | Option exercise | 844 | $95.10 | $80K | 5K |
| 2026-06-16 | Sakys John | CFO | Sell | 1K | $101.27 | $124K | 17K |
| 2026-06-16 | Crennen Lyndsey Elizabeth | CAO | Sell | 118 | $101.27 | $12K | 1K |
| 2026-06-16 | Archbold Brian David | SVP Operations | Sell | 1K | $101.27 | $117K | 4K |
| 2026-06-15 | Sakys John | CFO | Option exercise | 3K | $104.08 | $283K | 18K |
| 2026-06-15 | Archbold Brian David | SVP Operations | Option exercise | 2K | $104.08 | $255K | 5K |
| 2026-03-10 | Tripeny R Tony | Director | Buy | 1K | $76.00 | $100K | 5K |
| 2026-03-10 | Ladiwala Shiraz Shabanali | Director | Buy | 4K | $72.23 | $253K | 9K |
| 2026-03-10 | Capone Mark Christopher | Director | Buy | 1K | $76.35 | $99K | 3K |
| 2025-12-02 | Sullivan John James | Director | Gift | 2K | $0.00 | $0 | 25K |
| 2025-10-27 | Owens Gary M | President and CEO | Option exercise | 12K | $0.00 | $0 | 64K |
| 2025-08-15 | Sullivan John James | Director | Option exercise | 1K | $0.00 | $0 | 27K |
| 2025-08-15 | Tripeny R Tony | Director | Option exercise | 1K | $0.00 | $0 | 4K |
| 2025-08-15 | Ladiwala Shiraz Shabanali | Director | Option exercise | 2K | $0.00 | $0 | 5K |
| 2025-08-15 | Hall Shannon | Director | Option exercise | 1K | $0.00 | $0 | 4K |
| 2025-08-15 | Capone Mark Christopher | Director | Option exercise | 1K | $0.00 | $0 | 2K |
| 2025-08-15 | Alltoft Jennifer Sadie | Director | Option exercise | 1K | $0.00 | $0 | 5K |
| 2025-06-21 | Owens Gary M | President and CEO | Tax withholding | 1K | $95.82 | $138K | 53K |
| 2025-06-21 | Owens Gary M | President and CEO | Option exercise | 3K | $95.82 | $316K | 54K |
| 2025-06-21 | Sakys John | CFO | Tax withholding | 454 | $95.82 | $44K | 15K |
| 2025-06-21 | Sakys John | CFO | Option exercise | 1K | $95.82 | $99K | 15K |
| 2025-06-21 | Archbold Brian David | SVP Operations | Tax withholding | 385 | $95.82 | $37K | 2K |
| 2025-06-21 | Archbold Brian David | SVP Operations | Option exercise | 844 | $95.82 | $81K | 3K |
| 2025-06-18 | Owens Gary M | President and CEO | Tax withholding | 4K | $92.99 | $354K | 51K |
| 2025-06-18 | Owens Gary M | President and CEO | Option exercise | 9K | $92.99 | $810K | 55K |
| 2025-06-18 | Sakys John | CFO | Tax withholding | 1K | $92.99 | $116K | 14K |
| 2025-06-18 | Sakys John | CFO | Option exercise | 3K | $92.99 | $264K | 16K |
| 2025-06-18 | Archbold Brian David | SVP Operations | Tax withholding | 1K | $92.99 | $108K | 2K |
| 2025-06-18 | Archbold Brian David | SVP Operations | Option exercise | 3K | $92.99 | $238K | 3K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON7 Form 144 notices on file for MLAB worth $6.1M at the prices reported; 2 in the last 90 days worth $5.1M. Latest: Owens Gary M filed on 2026-08-27 to sell 20,358 shares ($2.6M) from 2026-08-27.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-27 | Owens Gary MFormer Officer | 20K | $2.6M | 0.364% | 2026-08-27 | Fidelity Brokerage Services LLC |
| 2026-08-21 | Owens Gary MFormer Officer | 20K | $2.5M | 0.357% | 2026-08-21 | Fidelity Brokerage Services LLC |
| 2026-06-22 | Sakys JohnOfficer | 3K | $253K | 0.051% | 2026-06-22 | Fidelity Brokerage Services LLC |
| 2026-06-22 | Archbold Brian DavidOfficer | 3K | $225K | 0.046% | 2026-06-22 | Fidelity Brokerage Services LLC |
| 2026-06-16 | Sakys JohnOfficer | 1K | $124K | 0.022% | 2026-06-16 | Fidelity Brokerage Services LLC |
| 2026-06-16 | Owens Gary MFormer Officer | 4K | $375K | 0.067% | 2026-06-16 | Fidelity Brokerage Services LLC |
| 2026-06-16 | Archbold Brian DavidOfficer | 1K | $117K | 0.021% | 2026-06-16 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON8 holders report 5% or more of MLAB in their latest filing, all on Schedule 13G (passive). The largest reported stake is Brian Paul Nelson at 8.6% of the class (477,126 shares), filed 2026-07-07 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-09 | 13G | Wasatch Advisors LPinvestment adviser | 387K | 6.9% | 2026-09-30 |
| 2026-07-07 | 13G/Ano. 2 | Brian Paul Nelsonindividual, parent holding company | 477K | 8.6% | 2026-06-30 |
| 2026-07-07 | 13G/Ano. 2 | William Thomas Brennanindividual, parent holding company | 477K | 8.6% | 2026-06-30 |
| 2026-07-07 | 13G/Ano. 2 | Long Path Holdings LLCother entity | 477K | 8.6% | 2026-06-30 |
| 2026-07-07 | 13G/Ano. 2 | Long Path Partners, LPinvestment adviser, partnership | 477K | 8.6% | 2026-06-30 |
| 2026-07-07 | 13G/Ano. 2 | Long Path Fund GP, LLCother entity | 477K | 8.6% | 2026-06-30 |
| 2026-07-07 | 13G/Ano. 2 | Long Path Smaller Companies Fund, LPpartnership | 477K | 8.6% | 2026-06-30 |
| 2026-03-27 | 13G/Ano. 6 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-10-02 | 13G/Ano. 10 | BlackRock, Inc.parent holding company | 379K | 6.9% | 2025-09-30 |
13F holders
Tracked managers holding MLAB at their latest 13F. JSON6 of the 30 tracked managers held MLAB at their latest 13F, $40.0M in total at quarter-end prices. AQR Capital Management is the largest at $20.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 204K | $20.3M | 0.01% | +33K |
| D. E. Shaw & Co. | 2026-06-30 | 82K | $8.1M | 0.00% | +27K |
| Citadel Advisors | 2026-06-30 | 36K | $3.6M | 0.00% | +27K |
| Two Sigma Investments | 2026-06-30 | 29K | $2.9M | 0.00% | +13K |
| Renaissance Technologies | 2026-06-30 | 29K | $2.9M | 0.00% | -3K |
| Point72 Asset Management | 2026-06-30 | 23K | $2.2M | 0.00% | +6K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q1 FY 2027 (quarter ended 2026-06-30) Mesa Laboratories reported revenue of $60.1M, up 1.0% from the same quarter a year earlier, and net income of $2.8M (0.49 diluted EPS). In FY 2026 it generated $42.8M of operating cash flow and spent $3.5M on dividends. As of 2026-06-30, cash was $30.7M against $66.1M of debt.
- Cash
- $30.7M
- Debt
- $66.1M
- Equity
- $188.8M
- Total assets
- $419.2M
- Shares outstanding
- 5,595,869
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q1 FY 2027 | 2026-06-30 | $60.1M | $2.8M | 4.7% | 0.49 |
| Q4 FY 2026derived | 2026-03-31 | $63.7M | -$4.1M | -6.5% | n/a |
| Q3 FY 2026 | 2025-12-31 | $65.1M | $3.6M | 5.6% | 0.65 |
| Q2 FY 2026 | 2025-09-30 | $60.7M | $2.5M | 4.1% | 0.45 |
| Q1 FY 2026 | 2025-06-30 | $59.5M | $4.7M | 8.0% | 0.85 |
| Q4 FY 2025derived | 2025-03-31 | $62.1M | -$7.1M | -11.4% | n/a |
| Q3 FY 2025 | 2024-12-31 | $62.8M | -$1.7M | -2.7% | -0.31 |
| Q2 FY 2025 | 2024-09-30 | $57.8M | $3.4M | 5.9% | 0.63 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2026 | 2026-03-31 | $249.1M | $6.7M | $42.8M | $3.3M | n/a | $3.5M |
| FY 2025 | 2025-03-31 | $241.0M | -$2.0M | $46.8M | $4.2M | n/a | $3.5M |
| FY 2024 | 2024-03-31 | $216.2M | -$254.2M | $44.1M | $2.6M | n/a | $3.4M |
| FY 2023 | 2023-03-31 | $219.1M | $930K | $28.0M | $4.5M | n/a | $3.4M |
| FY 2022 | 2022-03-31 | $184.3M | $1.9M | $39.2M | $4.4M | n/a | $3.3M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-03 from the cover page.
What this page is
Mesa Laboratories in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Mesa Laboratories (MLAB), SEC CIK 724004, listed on Nasdaq, classified by the SEC as industrial instruments for measurement, display, and control. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-12.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-03.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-27.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-09.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 724004Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as industrial instruments for measurement, display, and control
Other company pages
Datasets
Frequently Asked Questions
How much of MLAB is sold short?
What is MLAB's daily short volume?
Does MLAB have fails to deliver?
Are MLAB insiders buying or selling?
Have MLAB insiders filed to sell?
Who owns 5% or more of MLAB?
What did MLAB report last quarter?
Which tracked 13F managers own MLAB?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.